158 related articles for article (PubMed ID: 35434630)
1. Development of 2-deoxystreptamine-nucleobase conjugates for the inhibition of oncogenic miRNA production.
Tran TPA; Poulet S; Pernak M; Rayar A; Azoulay S; Di Giorgio A; Duca M
RSC Med Chem; 2022 Mar; 13(3):311-319. PubMed ID: 35434630
[TBL] [Abstract][Full Text] [Related]
2. Design and Implementation of Synthetic RNA Binders for the Inhibition of miR-21 Biogenesis.
Maucort C; Vo DD; Aouad S; Charrat C; Azoulay S; Di Giorgio A; Duca M
ACS Med Chem Lett; 2021 Jun; 12(6):899-906. PubMed ID: 34141067
[TBL] [Abstract][Full Text] [Related]
3. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
4. Building of neomycin-nucleobase-amino acid conjugates for the inhibition of oncogenic miRNAs biogenesis.
Vo DD; Becquart C; Tran TPA; Di Giorgio A; Darfeuille F; Staedel C; Duca M
Org Biomol Chem; 2018 Aug; 16(34):6262-6274. PubMed ID: 30116813
[TBL] [Abstract][Full Text] [Related]
5. Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
Tran TP; Vo DD; Di Giorgio A; Duca M
Bioorg Med Chem; 2015 Sep; 23(17):5334-44. PubMed ID: 26264847
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of miR-27a by neomycin-bisbenzimidazole conjugates.
Nahar S; Ranjan N; Ray A; Arya DP; Maiti S
Chem Sci; 2015 Oct; 6(10):5837-5846. PubMed ID: 29861909
[TBL] [Abstract][Full Text] [Related]
7. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates.
Vo DD; Tran TP; Staedel C; Benhida R; Darfeuille F; Di Giorgio A; Duca M
Chemistry; 2016 Apr; 22(15):5350-62. PubMed ID: 26928593
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of Bleomycin-Inspired RNA Ligands Targeting the Biogenesis of Oncogenic miRNAs.
Maucort C; Bonnet M; Ortuno JC; Tucker G; Quissac E; Verreault M; Azoulay S; Di Giorgio C; Di Giorgio A; Duca M
J Med Chem; 2023 Aug; 66(15):10639-10657. PubMed ID: 37449818
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery.
Tam VK; Kwong D; Tor Y
J Am Chem Soc; 2007 Mar; 129(11):3257-66. PubMed ID: 17319662
[TBL] [Abstract][Full Text] [Related]
11. Modulation of oncogenic miRNA biogenesis using functionalized polyamines.
Staedel C; Tran TPA; Giraud J; Darfeuille F; Di Giorgio A; Tourasse NJ; Salin F; Uriac P; Duca M
Sci Rep; 2018 Jan; 8(1):1667. PubMed ID: 29374231
[TBL] [Abstract][Full Text] [Related]
12. Targeting miRNA by tunable small molecule binders: peptidic aminosugar mediated interference in miR-21 biogenesis reverts epithelial to mesenchymal transition.
Ghosh A; Degyatoreva N; Kukielski C; Story S; Bhaduri S; Maiti K; Nahar S; Ray A; Arya DP; Maiti S
Medchemcomm; 2018 Jul; 9(7):1147-1154. PubMed ID: 30109002
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Surfactins as Inhibitors of MicroRNA Processing Using Cat-ELCCA.
Robertson AW; Sandoval J; Mohamed OG; Zhuang Y; Gallagher EE; Schmidt J; Caratelli L; Menon A; Schultz PJ; Torrez RM; Hay CL; Bell BA; Price PA; Garner AL; Tripathi A
ACS Med Chem Lett; 2021 Jun; 12(6):878-886. PubMed ID: 34141065
[TBL] [Abstract][Full Text] [Related]
14. Sequence requirements for micro RNA processing and function in human cells.
Zeng Y; Cullen BR
RNA; 2003 Jan; 9(1):112-23. PubMed ID: 12554881
[TBL] [Abstract][Full Text] [Related]
15. Dietary flavonoid narirutin as a prospective antagonist of oncogenic pri/pre-microRNAs.
Singh S; Srivastava PN; Meena A; Luqman S
Phytother Res; 2022 Feb; 36(2):963-983. PubMed ID: 35040205
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Fluorescence-Based Screen Identifies the Neuronal MicroRNA miR-124 as a Positive Regulator of Alphavirus Infection.
López P; Girardi E; Mounce BC; Weiss A; Chane-Woon-Ming B; Messmer M; Kaukinen P; Kopp A; Bortolamiol-Becet D; Fendri A; Vignuzzi M; Brino L; Pfeffer S
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102877
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of a 'plant-like' HYL1 homolog in the cnidarian
Tripathi AM; Admoni Y; Fridrich A; Lewandowska M; Surm JM; Aharoni R; Moran Y
Elife; 2022 Mar; 11():. PubMed ID: 35289745
[TBL] [Abstract][Full Text] [Related]
18. miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers.
Hua Y; Larsen N; Kalyana-Sundaram S; Kjems J; Chinnaiyan AM; Peter ME
BMC Genomics; 2013 Mar; 14():179. PubMed ID: 23497354
[TBL] [Abstract][Full Text] [Related]
19. Targeted Degradation of the Oncogenic MicroRNA 17-92 Cluster by Structure-Targeting Ligands.
Liu X; Haniff HS; Childs-Disney JL; Shuster A; Aikawa H; Adibekian A; Disney MD
J Am Chem Soc; 2020 Apr; 142(15):6970-6982. PubMed ID: 32233464
[TBL] [Abstract][Full Text] [Related]
20. Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis.
Chaulk SG; Thede GL; Kent OA; Xu Z; Gesner EM; Veldhoen RA; Khanna SK; Goping IS; MacMillan AM; Mendell JT; Young HS; Fahlman RP; Glover JN
RNA Biol; 2011; 8(6):1105-14. PubMed ID: 21955497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
